MacroGenics | MGNX - Loan Capital

Stock Price
1.81
Daily Change
0.11 6.47%
Monthly
0%
Yearly
-30.38%
Q1 Forecast
1.77

MacroGenics reported $70.26M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Amgen USD 52.43B 1.33B Sep/2025
AstraZeneca USD 6.55B 19.43B Sep/2025
Biogen USD 6.29B 1.4M Sep/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Daiichi Sankyo JPY 300.15B 199.41B Dec/2025
Eli Lilly USD 40.87B 6.69B Sep/2025
Genmab DKK 126M 6M Sep/2025
Geron USD 119.26M 273K Sep/2025
Gilead Sciences USD 22.14B 5M Sep/2025
J&J USD 39.41B 173M Sep/2025
MacroGenics USD 70.26M 4K Sep/2025
Merck USD 39.97B 6B Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Xencor USD 87.78M 6.96M Sep/2025